Ionq Inc SEC Filings

IonQ, Inc. (IONQ) initial Form 3 discloses that Dean P. Acosta, listed as an officer and director, filed an ownership statement reporting no securities beneficially owned as of the event date 10/06/2025. The filing includes an Exhibit 24 power of attorney and is signed on 10/08/2025. This is an initial Section 16 filing that records the reporting persons relationship to the issuer and indicates there are currently no direct or derivative holdings to report.

IonQ, Inc. filing a Form 144 notifies the market that 814,601 common shares may be sold through Merrill Lynch on or about 10/07/2025, with an aggregate market value of $65,157,738.64. The filing shows the shares were acquired by stock option: 107,661 shares on 05/17/2021 and 706,940 shares on 08/18/2022, both from Peter Chapman. The issuer has 324,861,092 shares outstanding. The filer certifies there are no undisclosed material adverse facts and that no sales were reported in the past three months.

IonQ, Inc. filed an Form 8-K reporting several non-financial items including an Unregistered Sale of Equity Securities and governance changes. The filing lists a Registration Rights Agreement dated October 2, 2025 between IonQ, Inc. and Fortis Advisors LLC, and it includes a Press Release dated October 7, 2025 as an exhibit. The document is signed by Paul T. Dacier, Chief Legal Officer and Corporate Secretary. The 8-K identifies Items 3.02, 5.02, 7.01, 8.01 and 9.01 but does not disclose transaction economics, share counts, or financial impacts within the provided text.

IonQ director Raymond John W received 3,063 restricted stock units (RSUs) on 09/25/2025 as reported on a Form 4. The RSUs were granted with no cash purchase price and are scheduled to vest in full on the earlier of the company’s 2026 Annual Meeting (or immediately prior if the reporting person’s directorship ends at that meeting) or June 18, 2026, provided the director remains in service through the vesting date. After this award the reporting person beneficially owns 3,063 shares directly. The filing was signed by an attorney-in-fact on 09/29/2025.

IonQ Form 3 summary: Raymond John W filed an initial Form 3 reporting his relationship to IonQ as a Director and that no securities are beneficially owned as of the 09/25/2025 event date. The filing includes an Exhibit 24 Power of Attorney and is signed by an attorney-in-fact, Kevin Caimi, dated 09/29/2025. The report indicates it was filed by one reporting person and provides the reporting person’s address at IonQ’s College Park, MD location.

Insider reported RSU awards and resulting beneficial ownership in IonQ, Inc. (IONQ). Robert T. Cardillo received two restricted stock unit awards on 09/10/2025: 45,600 RSUs that vest over four years (25% on 09/10/2026, then quarterly 1/16 on each Dec 10, Mar 10, Jun 10, Sep 10) and 31,920 RSUs that vest in full on 09/10/2027, both conditioned on continued service. Both awards were reported with a transaction price of $0. After the first award the reporting person beneficially owned 83,036 shares, and after the second award 114,956 shares. The filing was signed by an attorney-in-fact on 09/25/2025.

IonQ amended a prior 8-K to correct a typographical error and to confirm transaction terms. The amendment states the company delivered 25,372,150 shares of common stock plus $10,000,000 cash as the aggregate consideration at closing for the acquisition of Oxford Ionics Limited. The amendment corrects an earlier, incorrect share amount of 26,622,077. It also discloses a proposed issuance of 6,294,058 shares in connection with the Vector Atomic transaction, expected to close in the fourth quarter of 2025 and subject to customary conditions. The filing references a registration rights agreement and related press releases and confirms reliance on private offering exemptions for the share issuances.

IonQ announced a material acquisition and a separate pending equity transaction. The company completed the acquisition of Oxford Ionics by issuing 26,622,077 shares of common stock plus $10,000,000 in cash as consideration. IonQ also entered into an agreement to issue 6,294,058 shares to acquire Vector Atomic, with that transaction expected to close in the fourth quarter of 2025 subject to customary closing conditions. The filings referenced a Registration Rights Agreement related to Oxford Science Enterprises plc and press releases announcing the Oxford Ionics closing and the Vector Atomic agreement. The disclosure indicates reliance on private offering exemptions for the share issuances.